FR-190809 is primarily utilized in the field of medical research, particularly in the study of cardiovascular diseases. It functions as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH), which plays a significant role in the metabolism of epoxy fatty acids. By inhibiting sEH, FR-190809 helps to increase the levels of these fatty acids, which are known to have protective effects on the cardiovascular system. This makes it a valuable tool in investigating potential therapeutic strategies for conditions such as hypertension, atherosclerosis, and heart failure. Additionally, its application extends to studies on inflammation and pain management, as epoxy fatty acids also exhibit anti-inflammatory and analgesic properties. Researchers leverage FR-190809 to better understand the biochemical pathways involved in these processes and to develop novel treatments for related disorders.